- Fibrostenotic strictures in Crohn’s disease
-
Yoo JH, Holubar S, Rieder F
- KMID: 2508564
- Intest Res.
- 2020 Oct;18(4):379-401.
- doi: 10.5217/ir.2019.09148
The use of biologic agents including anti-tumor necrosis factor monoclonal antibodies followed by anti-integrins and anti-interleukins has drastically changed the treatment paradigm of Crohn’s disease (CD) by improving clinical symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
